Klinikverbund St. Antonius und St. Josef GmbH
- Address
- Bergstrasse 6-12, Elberfeld, 42105 Wuppertal, Germany
Klinikverbund St. Antonius und St. Josef GmbH - Systemic Sclerosis Research
Klinikverbund St. Antonius und St. Josef GmbH is a clinical research center with specialized expertise in autoimmune connective tissue diseases and their complications. The center focuses on investigating novel therapeutic approaches for complex systemic conditions that affect multiple organ systems, particularly those involving pulmonary manifestations.
- Systemic sclerosis-associated interstitial lung disease (SSc-ILD)
- Biologic therapies targeting immune-mediated lung disease
- Pulmonary function assessment and preservation strategies
The center participates in clinical trials evaluating advanced immunomodulatory treatments such as belimumab for patients with diffuse cutaneous systemic sclerosis-associated interstitial lung disease. Their research emphasizes measuring clinically meaningful outcomes, including preservation of forced vital capacity (FVC), to determine treatment efficacy in preventing progressive lung volume decline in this challenging patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinikverbund St. Antonius und St. Josef GmbH
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study | Horizon Therapeutics Ireland Designated Activity Company | Phase III | Not Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Belimumab | 1 | Unknown | 2024-05-22 | 2024-05-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.